MCM
LKFT

MAI Capital Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

MAI Capital Management’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1K Buy
70
+18
+35% +$596 ﹤0.01% 3904
2025
Q4 		$1.7K Hold
52
– – ﹤0.01% 3460
2025
Q3 		$1.8K Hold
52
– – ﹤0.01% 3330
2025
Q2 		$1.46K Buy
+52
New +$1.39K ﹤0.01% 3513

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MAI Capital Management's LKFT Position: Q1 2026 in Review

MAI Capital Management increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 35% in Q1 2026, buying an estimated $596 and bringing the position to 70 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3904.

MAI Capital Management first reported a position in LKFT in Q2 2025 and has held it in 4 quarters since. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • MAI Capital Management held 70 shares of Lakefront Biotherapeutics American Depositary Shares worth $2.1K as of Q1 2026.
  • MAI Capital Management bought 18 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $596.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #3904 holding.
  • MAI Capital Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2025 and has held it in 4 quarters since.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.